PAK4 and non-Hodgkin lymphoma: With two small molecule inhibitors of PAK4 currently being evaluated in Phase I basket trials in solid malignancies and non-Hodgkin lymphoma (NCT04281420, NCT02702492), Xu et al. recently reported that PAK4 could also be targeted by sEV-siRNA [208].